Frank Hübler

Frank Hübler is a member of the Board of Directors at Boehringer Ingelheim, responsible for finance. He has highlighted the company's substantial investments in research and development, amounting to approximately 25 billion EUR over the past five years, and is focused on continuing these investments to support innovation and growth within the company.